Fail Safe Cell Therapy

1-888-613-6862
info@pancella.com

Rapid isolation of bone marrow mesenchymal stromal cells using integrated centrifuge-based technology

Amanda M Meppelink, Xing-Hua Wang, Gino Bradica, Kathryn Barron, Kathleen Hiltz, Xiang-Hong Liu, Scott M Goldman, Joseph P Vacanti, Armand Keating, David M Hoganson
Cytotherapy 2016 Jun;18(6):729-39

The use of bone marrow–derived mesenchymal stromal cells (MSCs) in cell-based therapies is currently being developed for a number of diseases. Thus far, the clinical results have been inconclusive and variable, in part because of the variety of cell isolation procedures and culture conditions used in each study. A new isolation technique that streamlines the method of concentration and demands less time and attention could provide clinical and economic advantages compared with current methodologies…

–Source: http://www.sciencedirect.com/science/article/pii/S1465324916303152

Sorry, comments are closed for this post.